NASDAQ · Drug Manufacturers - Specialty & Generic

Akanda Corp. (AKAN) Stock

$1.76 -1.12% NASDAQ: AKAN Healthcare

Valuation

MetricValue
Price$1.76
Market Cap$56964
P/E Ratio-0.01
P/B Ratio-0.06
P/S Ratio0.09
EPS (TTM)$-257.60
52-Week High$78.90
52-Week Low$1.73
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE391.92%
ROA-791.92%
ROCE141.35%
Gross Margin-400.00%
Operating Margin-400.00%
Net Margin-6.20%
Debt/Equity-1.22
Current Ratio1.25

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$3.0M$2.0M$1.0M$0
Operating Profit$-3.0M$-20.0M$-10.0M$-4.0M$-5.0M
Net Profit$-8.0M$-12.0M$-32.0M$-4.0M$-46.0M
EPS$-14066.48$-16828.00$-2865532.00$-257.60$-662.22
Op Margin-6203.4%-770.2%-465.3%-523.8%-1931.0%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$8.0M$39.0M$9.0M$8.0M$6.0M
Total Liabilities$10.0M$12.0M$13.0M$4.0M$18.0M
Cash$3.0M$0$0$4.0M$1.0M
Borrowings$10.0M$4.0M$4.0M$0$14.0M

Latest News

Akanda Announces Receipt of Nasdaq Notice Regarding Minimum Stockholders' Equity Requirement TMX Newsfile · Jun 18, 2026 Why Is AKAN Stock Surging Today? Stocktwits · Jun 12, 2026 Akanda Shares Surge After Restoring Nasdaq Compliance (AKAN) InvestorsHub · Jun 12, 2026 Akanda Corp. Regains Compliance with Nasdaq Periodic Filing Requirement TMX Newsfile · Jun 12, 2026 Top Midday Decliners MT Newswires · May 26, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-7.0M$-11.0M$-2.0M$-4.0M$-7.0M
Investing Cash Flow$-1.0M$-5.0M$0$-3.0M$-9.0M
Financing Cash Flow$0$-1.0M$2.0M$-1.0M$0
Net Cash Flow$3.0M$-3.0M$0$4.0M$-3.0M
Free Cash Flow$-7.0M$-12.0M$-2.0M$-6.0M$-8.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-2.24
FCF Yield-20918.28%
Quick Ratio0.22
Interest Coverage-4.95
Return 1Y-88.99%
Return 3Y-99.73%
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BBLGBone Biologics Corp $0.47 -0.43% -0.26 $845628 0.00%
GCTKGlucoTrack, Inc. $1.03 -7.21% -0.01 $822087 0.00%
GNPXGenprex, Inc. $2.72 -1.09% -0.02 $1.37M 0.00%
HSCSHeartSciences Inc. $3.18 +4.61% -1.36 $6.87M 0.00%
IMCCIM Cannabis Corp. $1.58 -8.14% -1.13 $954195 0.00%

About Akanda Corp.

Akanda Corp. is led by CEO Katharyn Field, employs 46 people, headquartered in GB, publicly traded since 2022.

Akanda Corp. (AKAN) stock trades at $1.76 with a market capitalization of $56964. The stock is valued at a price-to-earnings (P/E) ratio of -0.01, price-to-book of -0.06, price-to-sales of 0.09. Over the past 52 weeks the stock has ranged between $1.73 and $78.90, and currently trades 97.8% below its 52-week high.

On profitability, Akanda Corp. generates a return on equity (ROE) of 391.92% — well above the market average, a sign of a high-quality business, return on capital employed of 141.35%, an operating margin of -400.00%, a net profit margin of -6.20%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides